Acadia Pharmaceuticals buy Cantor Fitzgerald
Start price
10.04.24
/
50%
€16.50
Target price
10.04.25
€34.38
Performance (%)
-5.36%
Price
26.04.24
€15.62
Summary
This prediction is currently active. With a performance of -5.36%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 10.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Acadia Pharmaceuticals | -2.131% |
iShares Core DAX® | 0.961% |
iShares Nasdaq 100 | 2.626% |
iShares Nikkei 225® | 0.217% |
iShares S&P 500 | 1.540% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
28.02.24
28.02.24
€38.75
28.02.25
28.02.25
-28.37%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.60
02.02.24
02.02.24
€38.87
02.02.25
02.02.25
-33.83%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€25.60
14.12.23
14.12.23
€38.21
14.12.24
14.12.24
-39.00%
26.04.24
26.04.24